Weighted average shares of common
stock outstanding used in
computing diluted net income per
share (c) 65,225 55,676 64,541 52,572
(a) Includes stock-based compensation of $247 and $0 for the three
months ended September 30, 2007 and 2006, respectively and $432 and
$0 for the nine months ended September 30, 2007 and 2006,
respectively.
(b) Includes stock-based compensation of $1,262 and $617 for the three
months ended September 30, 2007 and 2006, respectively and $2,358
and $1,440 for the nine months ended September 30, 2007 and 2006,
respectively.
(c) Weighted average diluted shares for the three and nine months ended
September 30, 2007 include 7,329 common shares related to the
Company's 3.5% Senior Convertible Notes. Such shares were
antidilutive for the three and nine months ended September 30, 2006.
Interest expense, net of tax, totaling $521 has been added back to
net income for the net income per diluted share calculation for the
three and nine months ended September 30, 2007.
Allscripts Healthcare Solutions, Inc.
Reconciliation of Non-GAAP Adjusted Earnings and Non-GAAP
Adjusted Earnings Per Share
(amounts in thousands, except per-share amounts)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Net Income $4,124 $3,262 $14,619 $7,412
Stock compensation expense (tax
effected at 40% for 2007 and
38% for 2006)
'/>"/>
| SOURCE Allscripts Healthcare Solutions, Inc. Copyright©2007 PR Newswire. All rights reserved |